Note: Gamida Cell's revenues are gauged from an analysis of company filings.
Gamida Cell's Income Statement (based on Industry Averages)
Gamida Cell P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Trademark Applications
Trademark applications show the products and services that Gamida Cell is developing and marketing.
Gamida Cell doesn't have any recent trademark applications, indicating Gamida Cell is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
NICORD Pharmaceutical preparations of stem cells derived from umbilical cord blood and expanded in culture for use in stem cell transplantation and regenerative therapy, in medical or clinical use
02/02/2021
INSPIRED TO CURE Cell therapy pharmaceutical preparations; pharmaceutical preparations in the field of hematology, oncology, leukemia, and blood and bone marrow diseases and disorders
07/07/2020
See all trademarks and details in the Full Report.
Market Share of Gamida Cell's Largest Competitors
A competitive analysis shows these companies are in the same general field as Gamida Cell, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Gamida Cell.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Gamida Cell and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.